Agios Pharmaceuticals, Inc.Agios Pharmaceuticals, Inc.Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

53.880.000.00%
The 8 analysts offering 1 year price forecasts for AGIO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to AGIO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AGIO EPS for the last quarter is 16.22 USD despite the estimation of 15.22 USD. In the next quarter EPS is expected to reach −1.68 USD. Track more of Agios Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Agios Pharmaceuticals, Inc. revenue is expected to reach ‪9.31 M‬ USD. Check out Agios Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, AGIO price target is 53.88 USD with a max estimate of 57.00 USD and a min estimate of 46.00 USD. Check if this forecast comes true in a year, meanwhile watch Agios Pharmaceuticals, Inc. stock price chart and keep track of the current situation with AGIO news and stock market news.
We've gathered opinions of 10 analysts rating AGIO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.